DoD selects Paragon Bioservices for Filovirus vaccine contract

Wednesday, January 18, 2012 12:15 PM

Paragon Bioservices has been awarded the JVAP-CBMS contract from the U.S. Department of Defense (DoD) to develop and manufacture the “VEE Replicon Particle Trivalent Filovirus Vaccine."

Paragon will develop a large-scale mammalian process suitable for cGMP manufacturing. Paragon will receive approximately $15 million, with a future optional CLINs that, if exercised, will more than double that amount.

This contract is being performed in parallel to a contract Paragon formed with the U.S. Army in October 2012, which involves process development and scale-up production to support the efficacy and potency of filovirus vaccine candidates against deadly Ebola and Marburg viruses.

Currently, there are no licensed vaccines or treatments against filoviruses, even though they are a potential agent of bioterrorism due to a 90% fatality rate in humans.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs